Cameron R G, Blendis L M, Neuman M G
Department of Pathology and Laboratory Medicine, Sunnybrook & Women's Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.
Clin Biochem. 2001 May;34(3):195-201. doi: 10.1016/s0009-9120(01)00215-6.
To determine what changes are occurring in patients with primary sclerosing cholangitis (PSC) by examining perisinusoidal macrophages (Kupffer cells) in liver biopsies; 2-to measure transforming growth factor beta (TGFbeta) as a marker of fibrosis in these patients.
Transmission electron microscopy and immunohistochemistry of 15 PSC, 26 primary biliary cirrhosis (PBC), 30 alcoholic liver disease (ALD) and 51 with normal histology was used. Five PSC, 30 ALD and 120 normal volunteers were sampled for serum levels of TGFbeta.
There was a three-fold increase in relative numbers of Kupffer cells in PSC compared to PBC and to patients whose livers had normal histology. In PSC there was an accumulation of perisinusoidal macrophages, which was not associated with focal necrosis or with cholestasis. The levels of TGFbeta in PSC were 54 +/- 2 in cirrhotic versus 34 +/- 5 in non-cirrhotic patients (p < 0.005).
The persistent activation of these macrophages may lead to the chronic release of TGFbeta and contribute to chronic inflammation, fibrosis and cirrhosis.
通过检查肝活检中的肝血窦周巨噬细胞(库普弗细胞)来确定原发性硬化性胆管炎(PSC)患者发生了哪些变化;2. 测量转化生长因子β(TGFβ)作为这些患者纤维化的标志物。
对15例PSC、26例原发性胆汁性肝硬化(PBC)、30例酒精性肝病(ALD)患者以及51例组织学正常者进行透射电子显微镜检查和免疫组织化学检测。对5例PSC、30例ALD患者和120名正常志愿者采集血清检测TGFβ水平。
与PBC患者以及肝脏组织学正常的患者相比,PSC患者库普弗细胞的相对数量增加了两倍。在PSC患者中,肝血窦周巨噬细胞有积聚现象,这与局灶性坏死或胆汁淤积无关。PSC患者肝硬化患者的TGFβ水平为54±2,非肝硬化患者为34±5(p<0.005)。
这些巨噬细胞的持续活化可能导致TGFβ的慢性释放,并促进慢性炎症、纤维化和肝硬化的发生。